Summary: ProSomnus Inc reported a 28% revenue increase for Q1 2024, totaling $7.5 million, despite undergoing Chapter 11 restructuring. The company maintained over 99% on-time delivery rates and continued progress on strategic initiatives. ProSomnus’s RPMO2 Next Generation Remote … [Read more...]
Harmony’s Q1 Report Shows Growth in Sleep/Wake Portfolio
Summary: Harmony Biosciences Holdings Inc described initially-quarter effects, showcasing development in its rest/wake portfolio. Key highlights consist of a rise in sufferers on Wakix, enhancements in the idiopathic hypersomnia program with designs for pitolisant, and positive … [Read more...]
Increased Demand for Sleep Devices Drives ResMed’s Q3 Growth
Summary: ResMed described a 7% revenue raise in its third fiscal quarter ending March 31, propelled by heightened demand from customers for sleep equipment and development in its mask item line. Earnings development was noted as 9% in the Americas and 3% in other intercontinental … [Read more...]
Rhythmlink Names New CEO to Helm Next Growth Phase
Summary: Rhythmlink Global has appointed Paul Buckman as CEO, succeeding co-founder Shawn Regan, who gets chairman. Buckman’s history in health-related products will guide Rhythmlink in growing its neurodiagnostic enterprise. Regan will go on his involvement as a strategic … [Read more...]